WallStreetZenWallStreetZen

NASDAQ: EXPO
Exponent Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for EXPO

Based on 1 analyst offering 12 month price targets for Exponent Inc.
Min Forecast
$120.00+16.04%
Avg Forecast
$120.00+16.04%
Max Forecast
$120.00+16.04%

Should I buy or sell EXPO stock?

Based on 1 analyst offering ratings for Exponent Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their EXPO stock forecasts and price targets.

EXPO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Truist Securities
Top 3%
98
Strong BuyMaintains$120.00+16.04%2022-04-05Find out why

1 of 1

Forecast return on equity

Is EXPO forecast to generate an efficient return?
Company
32.3%
Industry
34.56%
Market
48.27%
EXPO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EXPO forecast to generate an efficient return on assets?
Company
18.48%
Industry
10.62%
EXPO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EXPO earnings per share forecast

What is EXPO's earnings per share in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.85-3.14%
Avg 2 year Forecast
$2.04+6.81%
EXPO's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

EXPO revenue forecast

What is EXPO's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$462.7M-7.37%
Avg 2 year Forecast
$494.8M-0.93%
EXPO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EXPO earnings growth forecast

How is EXPO forecast to perform vs Consulting Services companies and vs the US market?
Company
-3.14%
Industry
0.02%
Market
68.81%
EXPO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
EXPO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
EXPO's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

EXPO revenue growth forecast

How is EXPO forecast to perform vs Consulting Services companies and vs the US market?
Company
-7.37%
Industry
0.67%
Market
5.27%
EXPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EXPO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EXPO vs Consulting Service Stocks

TickerPricePrice TargetUp/downsideConsensus
EXPO$103.41$120.00+16.04%Strong Buy
FCN$172.82$220.00+27.30%Strong Buy
ICFI$108.37$121.00+11.65%Buy
HURN$77.86$81.00+4.03%Strong Buy
CRAI$123.26$130.00+5.47%Buy

Exponent Stock Forecast FAQ

Is Exponent Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: EXPO) stock is to Strong Buy EXPO stock.

Out of 1 analyst, 1 (100%) are recommending EXPO as a Strong Buy, 0 (0%) are recommending EXPO as a Buy, 0 (0%) are recommending EXPO as a Hold, 0 (0%) are recommending EXPO as a Sell, and 0 (0%) are recommending EXPO as a Strong Sell.

If you're new to stock investing, here's how to buy Exponent stock.

What is EXPO's earnings growth forecast for 2022-2023?

(NASDAQ: EXPO) Exponent's forecast annual earnings growth rate of -3.14% is not forecast to beat the US Consulting Services industry's average forecast earnings growth rate of 0.02%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 68.81%.

Exponent's earnings in 2022 is $100,186,000.On average, 2 Wall Street analysts forecast EXPO's earnings for 2022 to be $93,680,724, with the lowest EXPO earnings forecast at $93,174,341, and the highest EXPO earnings forecast at $94,187,106.

In 2023, EXPO is forecast to generate $103,301,987 in earnings, with the lowest earnings forecast at $102,795,605 and the highest earnings forecast at $103,301,987.

What is EXPO's revenue growth forecast for 2022-2023?

(NASDAQ: EXPO) Exponent's forecast annual revenue growth rate of -7.37% is not forecast to beat the US Consulting Services industry's average forecast revenue growth rate of 0.67%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 5.27%.

Exponent's revenue in 2022 is $499,444,000.On average, 2 Wall Street analysts forecast EXPO's revenue for 2022 to be $23,427,776,647, with the lowest EXPO revenue forecast at $23,420,180,913, and the highest EXPO revenue forecast at $23,435,372,381.

In 2023, EXPO is forecast to generate $25,055,289,327 in revenue, with the lowest revenue forecast at $25,030,476,595 and the highest revenue forecast at $25,080,102,059.

What is EXPO's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: EXPO) forecast ROA is 18.48%, which is higher than the forecast US Consulting Services industry average of 10.62%.

What is EXPO's Price Target?

According to 1 Wall Street analyst that have issued a 1 year EXPO price target, the average EXPO price target is $120.00, with the highest EXPO stock price forecast at $120.00 and the lowest EXPO stock price forecast at $120.00.

The Wall Street analyst predicted that Exponent's share price could reach $120.00 by Apr 5, 2023. The average Exponent stock price prediction forecasts a potential upside of 16.04% from the current EXPO share price of $103.41.

What is EXPO's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: EXPO) Exponent's current Earnings Per Share (EPS) is $1.91. On average, analysts forecast that EXPO's EPS will be $1.85 for 2022, with the lowest EPS forecast at $1.84, and the highest EPS forecast at $1.86. In 2023, EXPO's EPS is forecast to hit $2.04 (min: $2.03, max: $2.04).

What is EXPO's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: EXPO) forecast ROE is 32.3%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.